Author

Mattu Tehtor Kroma

Observed names: M T Kroma, MT Kroma, Mattu Kroma, Mattu T. Kroma, Mattu Tehtor, Matu T. Kroma, Tehtor, Mattu

Institutions: University of Sierra Leone, London School of Hygiene & Tropical Medicine, Ministry of Health and Sanitation, MRC Unit the Gambia, Medical Research Council

Observed institutions: University of Sierra Leone, London School of Hygiene & Tropical Medicine, Ministry of Health and Sanitation, MRC Unit the Gambia, Medical Research Council

ORCID: 0000-0002-7265-7509

Observed ORCID: 0000-0002-7265-7509

OpenAlex ID: A5080351129

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

2021 · Muhammed O Afolabi, David Ishola, et al. · The Lancet Infectious Diseases · 94

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

2021 · David Ishola, Daniela Manno, et al. · The Lancet Infectious Diseases · 93

Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial

2022 · Daniela Manno, Agnes Bangura, et al. · The Lancet Infectious Diseases · 26

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

2023 · Edward Man-Lik Choi, Boris Lacarra, et al. · The Lancet Global Health · 18

Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols

2022 · Frank Baiden, Suzanne Fleck, et al. · PLoS ONE · 9

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen

2023 · Daniela Manno, Catriona Patterson, et al. · Vaccines · 4

Characterising recent antimalarial resistance in West Africa: Insights from amplicon sequencing of 17,384 Plasmodium falciparum infection samples

2026 · Joyce M. Ngoi, Eniyou C. Oriero, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3

First Report of Dengue Virus in Sierra Leone: Implications for Arbovirus Surveillance and Control

2025 · Allan K. O. Campbell, Ifeanyi F. Omah, et al. · Research Square · 3

Characterising recent antimalarial resistance in West Africa: Insights from amplicon sequencing of 17,384 Plasmodium falciparum infection samples

2026 · Joyce M. Ngoi, Eniyou C. Oriero, et al. · Wellcome Open Research

A Heterologous 2-dose Strategy for an Ebola Virus Vaccine Using Adenovirus Type 26 and Modified Vaccinia Virus Ankara–Vectored Ebola Induces a Robust, Increased Cellular Immune Response in Sierra Leonean Volunteers

2026 · Abdoulie Drammeh, Marvin Joven Turyasingura, et al. · Research Square

Characterisation of the First Complete Dengue Genome in Sierra Leone

2026 · Allan K. O. Campbell, Ifeanyi Omah, et al. · Viruses

Works count: 12

Citation count: 250

H-index: 5

I10-index: 4